11 Aug
BSE CLOSED @ 54525.93 ❌ 28.73 Points
NSE CLOSED @ 16282.25 ✅ 2.15 Points
BankNifty Closed 35806.40 ❌ 227.70. Points
India VIX Closed 12.7125 ✅ 0.0075 Points.
11 Aug
BSE CLOSED @ 54525.93 ❌ 28.73 Points
NSE CLOSED @ 16282.25 ✅ 2.15 Points
BankNifty Closed 35806.40 ❌ 227.70. Points
India VIX Closed 12.7125 ✅ 0.0075 Points.
Analysts & Investors Meeting
Angel Broking: The company's officials will meet investors on August 11 in a conference call hosted by Citigroup Global Markets India.
VIP Industries: The company's officials will meet analysts and institutional investors on August 11, for discussing company's performance for June quarter.
India Cements: The company's officials will meet investors and analysts on August 11 post financial results.
Motherson Sumi Systems: The company's officials will meet investors in Investment delegation Conference organised by Spark Capital on August 11, and Annual Corporate Conference by Emkay on August 12.
Max Healthcare Institute: The company's officials will meet Fidelity Management & Research (Hong Kong) on August 11, Briarwood and TR Capital on August 12.
Welspun Corp: The company's officials will meet Authum Investment & Infrastructure on August 11.
Globus Spirits: The company's officials will meet investors and analysts on August 11, in Emkay Confluence Conference.
Mrs. Bectors Food Specialities: The company's officials will meet analysts aqnd investors on August 12 post announcement of financial results.
Can Fin Homes: The company's officials will meet My Lead Fintech on August 12, and Quantum Securities on August 16.
AIA Engineering: The company's officials will meet investors on August 13, to discuss the financial performance.
Stocks in News
Aarey Drugs & Pharmaceuticals: The company reported higher profit at Rs 2.5 crore in Q1FY22 against Rs 1.35 crore in Q1FY21, revenue increased to Rs 97.51 crore from Rs 25.21 crore YoY.
Fortis Malar Hospitals: The company reported consolidated loss at Rs 1.34 crore in Q1FY22 against loss of Rs 2.91 crore in Q1FY21, revenue rose to Rs 23.18 crore from Rs 9.43 crore YoY.
Nath Bio-Genes (India): The company reported higher profit at Rs 44.91 crore in Q1FY22 against Rs 41.25 crore in Q1FY21, revenue increased to Rs 215.1 crore from Rs 193.64 crore YoY.
Pricol: The company reported consolidated profit at Rs 5.94 crore in Q1FY22 against loss of Rs 30.85 crore in Q1FY21, revenue rose to Rs 319.91 crore from Rs 120 crore YoY.
Gujarat Alkalies and Chemicals: The company reported higher consolidated profit at Rs 63.12 crore in Q1FY22 against Rs 31.81 crore in Q1FY21, revenue increased to Rs 716.44 crore from Rs 469.61 crore YoY.
Ahluwalia Contracts (India): The company reported higher consolidated profit at Rs 34.78 crore in Q1FY22 against Rs 7.47 crore in Q1FY21, revenue jumped to Rs 580.09 crore from Rs 249.84 crore YoY.
SHORT TERM CALL Buy Suven Life Sciences Cmp 63 SL Below 55 Tgt 66 / 69 / 72 / 75 / 78++ In Coming Days..